Real-world findings helped in decision making to remove drug’s prior authorization EAGAN, Minn., Oct. 20, 2020 /PRNewswire/ — Sacubitril-valsartan (Entresto®) has been proven to decrease hospitalization and reduce death due to heart failure with reduced ejection fraction (HFrEF) also known as systolic heart failure. 1 According to a recent study by Prime Therapeutics LLC […]
Financial
Brain Scientific Appoints Stuart Bernstein as VP of Marketing
NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) — via NewMediaWire ‒ Brain Scientific Inc. (OTCQB: BRSF), a neurology-focused medical device and software company, today announced the appointment of Stuart Bernstein as Vice President of Marketing. In this role, Bernstein will be responsible for Brain Scientific’s overall marketing strategy and efforts to strengthen the company’s market […]
Integer Receives Patent Litigation Payment
Uses Cash to Pay Down Debt PLANO, Texas, Oct. 19, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, received approximately $28 million following the Federal Court of Appeals for the Federal Circuit affirming, in all respects, the ruling in Integer’s favor granted […]
Philips announces Q3 2020 results and provides new financial targets for the 2021–2025 period
October 19, 2020 Philips delivers Q3 sales of EUR 5.0 billion, with 10% comparable sales growth; income from continuing operations increases to EUR 341 million, Adjusted EBITA margin improves 300 basis points to 15.4%, and operating cash flow increases to EUR 770 million Philips provides new financial targets for the […]
Esperion to Report Third Quarter 2020 Financial Results November 2, 2020
ANN ARBOR, Mich., Oct. 19, 2020 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR), today announced it will report third quarter 2020 financial results after the close of the U.S. financial markets on Monday, November 2, 2020. Following the release, company management will host a webcast and conference call at 4:30 p.m. […]
Itamar Medical Announces Appointment of Shane Brown as President – U.S.
CAESAREA, Israel, Oct. 19, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the diagnosis of sleep apnea and other respiratory sleep disorders, today announced that Shane Brown has been appointed President – U.S., effective immediately. In the new role, Mr. […]
Quantum Genomics Enters into Exclusive Licensing and Collaboration Agreement with Qilu Pharmaceutical
Quantum Genomics to receive up to $50 million in upfront and milestone payments plus double-digit royalties on sales Qilu Pharmaceutical to receive an exclusive license to develop and commercialize firibastat for the treatment of difficult to treat/resistant hypertension in Greater China region, including Hong Kong and Macao PARIS and NEW […]
Sequana Medical Appoints Two Additional Experts as Heart Failure Scientific Advisors
Dr. Felker and Dr. Udelson join current advisors to support the development of alfapump® DSR for the management of fluid overload in patients with heart failure GHENT, Belgium, Oct. 15, 2020 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA), an innovator in the management of fluid overload in liver disease, malignant ascites and heart failure, today announces the appointments of Dr. Michael […]
Philips and Mandaya Royal Hospital Puri sign seven-year partnership agreement to provide patient-centered care
October 15, 2020 Turnkey solution for newly-built hospital combines latest innovations in enterprise diagnostic imaging, connected care and informatics, as well as service, maintenance and financing Amsterdam, the Netherlands and Jakarta, Indonesia – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Mandaya Royal Hospital Puri today announced a seven-year strategic […]
Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
CALGARY, Oct. 14, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announced today that Vision Leader Limited, a wholly-owned subsidiary of ORI Star Fund LP (“ORI”), has delivered a notice of conversion to convert its entire September 2019 debenture and associated interest, into Resverlogix common shares, which […]



